247 related articles for article (PubMed ID: 24847272)
1. Pharmacogenomics of human P450 oxidoreductase.
Pandey AV; Sproll P
Front Pharmacol; 2014; 5():103. PubMed ID: 24847272
[TBL] [Abstract][Full Text] [Related]
2. P450 Oxidoreductase deficiency: Analysis of mutations and polymorphisms.
Burkhard FZ; Parween S; Udhane SS; Flück CE; Pandey AV
J Steroid Biochem Mol Biol; 2017 Jan; 165(Pt A):38-50. PubMed ID: 27068427
[TBL] [Abstract][Full Text] [Related]
3. In Silico Analysis of PORD Mutations on the 3D Structure of P450 Oxidoreductase.
Nurhafizuddin M; Azizi A; Ming LC; Shafqat N
Molecules; 2022 Jul; 27(14):. PubMed ID: 35889519
[TBL] [Abstract][Full Text] [Related]
4. Consequences of POR mutations and polymorphisms.
Miller WL; Agrawal V; Sandee D; Tee MK; Huang N; Choi JH; Morrissey K; Giacomini KM
Mol Cell Endocrinol; 2011 Apr; 336(1-2):174-9. PubMed ID: 21070833
[TBL] [Abstract][Full Text] [Related]
5. Cytochrome P450 oxidoreductase deficiency caused by R457H mutation in POR gene in Chinese: case report and literature review.
Bai Y; Li J; Wang X
J Ovarian Res; 2017 Mar; 10(1):16. PubMed ID: 28288674
[TBL] [Abstract][Full Text] [Related]
6. Diversity and function of mutations in p450 oxidoreductase in patients with Antley-Bixler syndrome and disordered steroidogenesis.
Huang N; Pandey AV; Agrawal V; Reardon W; Lapunzina PD; Mowat D; Jabs EW; Van Vliet G; Sack J; Flück CE; Miller WL
Am J Hum Genet; 2005 May; 76(5):729-49. PubMed ID: 15793702
[TBL] [Abstract][Full Text] [Related]
7. P450 oxidoreductase deficiency: a new disorder of steroidogenesis.
Miller WL; Huang N; Pandey AV; Flück CE; Agrawal V
Ann N Y Acad Sci; 2005 Dec; 1061():100-8. PubMed ID: 16467261
[TBL] [Abstract][Full Text] [Related]
8. Cytochrome P450 oxidoreductase deficiency: rare congenital disorder leading to skeletal malformations and steroidogenic defects.
Fukami M; Ogata T
Pediatr Int; 2014 Dec; 56(6):805-808. PubMed ID: 25294558
[TBL] [Abstract][Full Text] [Related]
9. Novel phenotypes and genotypes in Antley-Bixler syndrome caused by cytochrome P450 oxidoreductase deficiency: based on the first cohort of Chinese children.
Fan L; Ren X; Song Y; Su C; Fu J; Gong C
Orphanet J Rare Dis; 2019 Dec; 14(1):299. PubMed ID: 31888681
[TBL] [Abstract][Full Text] [Related]
10. P450 oxidoreductase deficiency: a disorder of steroidogenesis with multiple clinical manifestations.
Miller WL
Sci Signal; 2012 Oct; 5(247):pt11. PubMed ID: 23092891
[TBL] [Abstract][Full Text] [Related]
11. Antley-Bixler syndrome arising from compound heterozygotes in the P450 oxidoreductase gene: a case report.
Li H; Zhao A; Xie M; Chen L; Wu H; Shen Y; Wang H
Transl Pediatr; 2021 Dec; 10(12):3309-3318. PubMed ID: 35070845
[TBL] [Abstract][Full Text] [Related]
12. Instability of the Human Cytochrome P450 Reductase A287P Variant Is the Major Contributor to Its Antley-Bixler Syndrome-like Phenotype.
McCammon KM; Panda SP; Xia C; Kim JJ; Moutinho D; Kranendonk M; Auchus RJ; Lafer EM; Ghosh D; Martasek P; Kar R; Masters BS; Roman LJ
J Biol Chem; 2016 Sep; 291(39):20487-502. PubMed ID: 27496950
[TBL] [Abstract][Full Text] [Related]
13. NADPH P450 oxidoreductase: structure, function, and pathology of diseases.
Pandey AV; Flück CE
Pharmacol Ther; 2013 May; 138(2):229-54. PubMed ID: 23353702
[TBL] [Abstract][Full Text] [Related]
14. Congenital adrenal hyperplasia due to P450 oxidoreductase deficiency.
Zhang J; Woo KL; Hai Y; Wang S; Lin Y; Huang Y; Peng X; Wu H; Zhang S; Yan L; Li Y
Front Endocrinol (Lausanne); 2022; 13():1020880. PubMed ID: 36518257
[TBL] [Abstract][Full Text] [Related]
15. Clinical, structural and functional implications of mutations and polymorphisms in human NADPH P450 oxidoreductase.
Flück CE; Nicolo C; Pandey AV
Fundam Clin Pharmacol; 2007 Aug; 21(4):399-410. PubMed ID: 17635179
[TBL] [Abstract][Full Text] [Related]
16. Delayed diagnosis of disorder of sex development (DSD) due to P450 oxidoreductase (POR) deficiency.
Koika V; Armeni AK; Georgopoulos NA
Hormones (Athens); 2016 Apr; 15(2):277-282. PubMed ID: 27376429
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms in cytochrome P450 oxidoreductase and its effect on drug metabolism and efficacy.
Gong L; Zhang CM; Lv JF; Zhou HH; Fan L
Pharmacogenet Genomics; 2017 Sep; 27(9):337-346. PubMed ID: 28731962
[TBL] [Abstract][Full Text] [Related]
18. Computational identification and analysis of deleterious non-synonymous single nucleotide polymorphisms (nsSNPs) in the human
Kumar R; Jayaraman M; Ramadas K; Chandrasekaran A
J Biomol Struct Dyn; 2024; 42(3):1518-1532. PubMed ID: 37173831
[TBL] [Abstract][Full Text] [Related]
19. Reduction in hepatic drug metabolizing CYP3A4 activities caused by P450 oxidoreductase mutations identified in patients with disordered steroid metabolism.
Flück CE; Mullis PE; Pandey AV
Biochem Biophys Res Commun; 2010 Oct; 401(1):149-53. PubMed ID: 20849814
[TBL] [Abstract][Full Text] [Related]
20. Ambiguous genitalia, impaired steroidogenesis, and Antley-Bixler syndrome in a patient with P450 oxidoreductase deficiency.
But WM; Lo IF; Shek CC; Tse WY; Lam ST
Hong Kong Med J; 2010 Feb; 16(1):59-62. PubMed ID: 20124576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
